Bendamustine Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-250

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bendamustine Hydrochloride (NDC 16729-250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bendamustine Label (Bendamustine 100mg Carton)

Packaging label for bendamustine hydrochloride injection, USP 100 mg/vial by Accord Healthcare, Inc. The sterile, single-dose vial contains 100 mg bendamustine hydrochloride, requires reconstitution and dilution for intravenous infusion, and includes storage instructions and handling precautions. The label features barcodes and manufacturer information.*

FDA Label Image

Bendamustine Label (Bendamustine 100mg Label)

Label for Bendamustine Hydrochloride for Injection, USP, 100 mg per vial, lyophilized powder for intravenous infusion, single-dose vial. The label includes dosage reconstitution instructions, storage conditions, manufacturer details including Accord Healthcare, Inc., and Intas Pharmaceuticals Limited, barcode, and a blank area for lot and expiration information.*

FDA Label Image

Bendamustine Label (Bendamustine 25mg Carton)

Packaging label for Bendamustine Hydrochloride for Injection, USP, 25 mg per vial. The sterile, single-dose vial is intended for intravenous infusion only and requires reconstitution and dilution as per the insert. Manufactured by Intas Pharmaceuticals and labeled by Accord Healthcare, Inc. The label includes dosage instructions, storage conditions, and handling precautions including the need for gloves and safety glasses.*

FDA Label Image

Bendamustine Label (Bendamustine 25mg Label)

Label for Bendamustine Hydrochloride for Injection, USP, 25 mg per vial, sterile single-dose vial for intravenous infusion. The label indicates the need for reconstitution and dilution before use. Manufactured by Intas Pharmaceuticals Limited and labeled by Accord Healthcare, Inc. Includes storage and handling instructions, batch coding area, and barcodes.*

FDA Label Image

Figure 1. Progression-free Survival (Bendamustine Fig 1)

A survival distribution function chart comparing progression-free survival (in months) between bendamustine hydrochloride treatment and chlorambucil. The x-axis represents progression-free survival time up to 45 months, and the y-axis shows survival distribution function from 0 to 1.*

FDA Label Image

Structural Formula (Bendamustine Structure)

Chemical structure of bendamustine hydrochloride showing its molecular arrangement with chlorine, nitrogen, carbon, and hydrogen atoms, including the hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.